Our research in oncology
We will continue to transform the lives of people with cancer through our groundbreaking science and medicines. Until we can offer every person with cancer a better, healthier life, our job is not done.
Featured in oncology
Intended for healthcare professionals, scientific audiences and media.
Our cancer research strategy leverages our molecular and clinical expertise and deep understanding of causal human biology to guide scientific discovery. Cutting-edge capabilities, differentiated platforms and a precision approach to research and development uniquely position us to attack cancer from every angle.
Bristol Myers Squibb is addressing the complexities of cancer through multiple research approaches.
Our oncology focus areas
Earlier stages of cancer
We are leading innovative science with the use of immunotherapies in earlier stages of cancer, especially for patients whose tumors could be removed by surgery. We believe that exploring the use of immunotherapy in earlier stages of cancer is important because of its potential to help prevent recurrence and address unmet needs as we work towards a cure for patients.
Scientific and disease-state resources
Explore our stories
Gastrointestinal cancers
We have helped advance the treatment of gastrointestinal cancers including esophageal cancer, gastric, gastroesophageal junction, hepatocellular carcinoma (liver) and colorectal cancer through an understanding of the needs that still remain for patients.
Scientific and disease-state resources
Explore our stories
Genitourinary cancers
Our portfolio and pipeline for genitourinary cancers spans multiple tumor types including bladder, kidney, as well as prostate*. We are exploring immunotherapies and targeted agents across multiple stages of cancer with the goal of helping address the unique needs of GU cancer patients.
* Pipeline only.
Scientific and disease-state resources
Explore our stories
Melanoma (skin cancer)
By harnessing the power of immunotherapy, we have helped transform the melanoma treatment landscape over the last decade and helped improve survival rates for patients. Today, we continue our research in both early and advanced stages of cancer to further advance the science.
Scientific and disease-state resources
Explore our stories
Thoracic cancers
We have helped redefine the treatment landscape for thoracic cancers and helped extend survival outcomes for patients. With both targeted medicines and immunotherapies, we aim to provide patients with safe and effective treatment options.
Scientific and disease-state resources
Explore our stories
Women's cancers
Breast cancer is the most frequently diagnosed cancer worldwide. We are researching novel immunotherapy treatment approaches and combinations for people living with breast, ovarian, and cervical cancers.
Scientific and disease-state resources
Explore our stories
Explore our scientific resources
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. As global citizens, we work sustainably and responsibly to create a positive impact in the communities where we live and work.